Aziyo Biologics, Inc. (AZYO) Tops Q1 EPS by 8c

Aziyo Biologics, Inc. (NASDAQ: AZYO) reported Q1 EPS of ($0.49), $0.08 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $13.7 million.

For earnings history and earnings-related data on Aziyo Biologics, Inc. (AZYO) click here.

You May Also Be Interested In

• Norwegian Cruise Line Holdings (NYSE: NCLH) PT Raised to $20 at UBS
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded